Primary Site >> Biliary tract Cancer
Gene >> ROS1
|
|
|
|
|
|---|---|---|---|---|
|
Ref: Mouse model of intrahepatic cholangiocarcinoma validates FIG-ROS as a potent fusion oncogene and therapeutic target. PMID: 24154728 |
Ref: Fibroblast growth factor receptor 2 tyrosine kinase fusions define a unique molecular subtype of cholangiocarcinoma. PMID: 24122810 Ref: Fibroblast growth factor receptor 2 translocations in intrahepatic cholangiocarcinoma. PMID: 24837095 Ref: Downregulation of ROS-FIG inhibits cell proliferation, colonyformation, cell cycle progression, migration and invasion, while inducing apoptosis in intrahepatic cholangiocarcinoma cells. PMID: 24968753 Ref: Screening for the FIG-ROS1 fusion in biliary tract carcinomas by nested PCR. PMID: 25231053 |
Ref: Clinical and pathological significance of ROS1 expression in intrahepatic cholangiocarcinoma. PMID: 26475437 |
Ref: Molecular Pathogenesis and Targeted Therapies for Intrahepatic Cholangiocarcinoma. PMID: 26405193 Ref: The landscape of targeted therapies for cholangiocarcinoma: current status and emerging targets. PMID: 27102149 Ref: Expression levels of ROS1/ALK/c-MET and therapeutic efficacy of cetuximab plus chemotherapy in advanced biliary tract cancer. PMID: 27136744 |
Ref: Rare Incidence of ROS1 Rearrangement in Cholangiocarcinoma. PMID: 27121721 |